Siemens Healthineers Unveils Groundbreaking Medical Imaging Innovations at Arab Health 2025
Siemens Healthineers, a global leader in medical technology, is set to revolutionize medical imaging with the debut of its cutting-edge technologies at Arab Health 2025, held from January 27 to 30 at the Dubai World Trade Centre.
Highlighting its commitment to advancing healthcare sustainably, the company introduces the NAEOTOM® Alpha class, powered by Quantum Technology and AI, and the MAGNETOM Flow platform, a next-generation 1.5T MRI solution.
The NAEOTOM® Alpha class, comprising three photon-counting CT systems, delivers unprecedented anatomical precision with Quantum HD resolution up to 0.2 mm and Quantum Spectral imaging for functional evaluations. Vivek Kanade, Managing Director for the Middle East and Africa, remarked, 'At Siemens Healthineers, innovation drives everything we do. Our solutions empower healthcare professionals to make precise, timely decisions, transforming patient care worldwide.'
The MAGNETOM Flow platform enhances sustainability with low power consumption, shorter examination times, and improved patient comfort, ensuring efficient and cooperative MRI experiences. Visitors can also explore advanced solutions such as the ACUSON Sequoia 3.5 for AI-driven ultrasound, the Biograph Trinion PET/CT for exceptional diagnostic accuracy, and cutting-edge X-ray platforms like the LUMINOS Q.namix and MAMMOMAT B.brilliant.
Siemens Healthineers' booth (S1.C10) offers an immersive, patient-centric journey through clinical pathways in oncology, neurology, and cardiology. The exhibit showcases innovations in diagnostic imaging and cancer therapy while underscoring collaborations with healthcare providers in the Middle East to advance equity, access, and sustainability.
Guided by its purpose — "We pioneer breakthroughs in healthcare. For everyone. Everywhere. Sustainably" — Siemens Healthineers invites visitors to experience the future of care delivery at Arab Health 2025.
News Source: Gambit Communications
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
TECHx
5 days ago
- TECHx
Check Point Launches Quantum Smart-1 Appliances
Home » Emerging technologies » Cyber Security » Check Point Launches Quantum Smart-1 Appliances Check Point® Software Technologies Ltd. (NASDAQ: CHKP) has announced the launch of its next-generation Quantum Smart-1 Management Appliances. The company is a global leader in cybersecurity solutions. The new appliances deliver a 2X increase in managed gateways. They also offer up to 70% higher log processing speeds. These improvements are designed to meet the complex demands of hybrid enterprises. Check Point revealed that the appliances are fully integrated into the Check Point Infinity Platform. This integration enhances threat detection and response using a hybrid mesh architecture. It also supports connections with over 250 third-party solutions. Nataly Kremer, Chief Product Officer at Check Point, stated that security teams are under pressure from AI-generated threats and fragmented infrastructures. She said the new appliances simplify these challenges through AI, automation, and precision. The rise of remote work and distributed teams has increased vulnerabilities. Check Point Research reported that AI services are now used in over 51% of enterprise networks each month. This growth widens security risks, making advanced security policies essential. According to Check Point, the Quantum Smart-1 Management Appliances help security teams operate faster and smarter across on-premises, cloud, and remote environments. Key features include: Managing up to 10,000 gateways, enabling scale without rearchitecting. Achieving up to 70% higher log speeds for faster threat response. Storing up to 70TB of logs locally to meet compliance needs. The appliances unify security operations and reduce complexity in hybrid environments. They are available in five models, including the high-performance 7000 Ultra. Check Point confirmed that the new models support tools like Infinity AI Copilot, Playblocks, Policy Advisor, Compliance, and Infinity AIOps. These tools streamline policy and firewall management. Miercom recently named Check Point the top performer in its AI-Powered Cyber Security Platform Benchmark. The report recognized Check Point's superior management usability and threat prevention. Rob Smithers, CEO of Miercom, said Check Point's Infinity Platform outperformed its peers. He added that its AI-driven design and hybrid mesh model set a new standard in cybersecurity. Check Point continues to advance cybersecurity with AI-powered solutions tailored for modern enterprise needs.
Al Etihad
5 days ago
- Al Etihad
M42, AstraZeneca, SOPHiA GENETICS to transform cancer diagnosis, care
3 June 2025 14:30 ABU DHABI (ALETIHAD)M42, a global health leader powered by technology, announced a strategic collaboration with AstraZeneca and SOPHiA GENETICS to bring cutting-edge liquid biopsy testing to the UAE, aimed at advancing cancer diagnosis, informing treatment decisions, and enabling faster, accurate biomarker testing across a broad range of part of the collaboration, M42 will integrate SOPHiA GENETICS' MSK-ACCESS®, powered with SOPHiA DDM™ technology, into its testing infrastructure, enabling non-invasive genomic profiling of cancers through a simple blood approach does not replace but rather complements routine cancer screenings, and is designed for patients who are unable to undergo a solid tumor biopsy, enabling them to be matched with a precision therapy tailored to their specific cancer the next 12 months, the partnership will enable liquid biopsy testing access across select leading hospitals across the UAE, providing patients with faster, less invasive biomarker insights compared to traditional tissue biopsies, while also strengthening testing infrastructure and capabilities for a wide range of cancers in the new testing programme will initially target lung, ovarian, breast, colorectal, and pancreatic cancers, among others, addressing some of the most critical cancer burdens in the studies are set to commence shortly at Cleveland Clinic Abu Dhabi, marking a key milestone toward the full clinical launch planned for the latter part of Q2 El-khani, Senior Vice President, Operations, Integrated Health Solutions at M42, said, 'This collaboration reflects our vision of democratising health by making advanced diagnostics accessible to more patients, supporting not just early diagnosis but also real-time treatment monitoring and cost-effective, precise, predictive, and personalised care.'Sameh El Fangary, Cluster President GCC of AstraZeneca, stated, "Our work, and our collaborations with partners across industry, are driving towards better treatments for patients as well as a more sustainable future for healthcare systems. Through our latest partnerships, we are committed to transforming cancer care for millions in the region by advancing early diagnosis and optimising patient pathways from detection to therapy.' Ross Muken, President of SOPHiA GENETICS, said, "Expanding access to advanced testing technologies is central to our mission at SOPHiA GENETICS. Partnering with M42 and AstraZeneca in the UAE allows us to equip healthcare providers with the tools they need to personalise care, monitor disease in real-time, and ultimately improve outcomes for patients across the region." Source: Aletihad - Abu Dhabi
Broadcast Pro
30-05-2025
- Broadcast Pro
Northrop invests $50m in Firefly Aerospace to advance Eclipse launch vehicle
The vehicle is being built on a hybrid foundation that draws from Northrop Grummans Antares platform and Fireflys Alpha rocket technology. Northrop Grumman Corporation has invested $50m into Firefly Aerospace to further advance production of their co-developed medium launch vehicle, now known as Eclipse. The companies continue to make progress in the development of Eclipse flight hardware, with qualification testing underway and more than 60 Miranda engine hot fire tests performed to date. Jason Kim, CEO of Firefly Aerospace, said: 'Firefly is incredibly grateful for Northrop Grummans investment that further solidifies our first-of-its-kind partnership to build the first stage of Antares 330 and jointly develop Eclipse. Eclipse represents two powerful forces coming together to transform the launch market with decades of flight heritage, a rapid, iterative approach, and bold innovation. With a 16 metric ton to orbit capability, Eclipse is a sweet spot for programs like NSSL Lane 1 and a natural fit to launch proliferated constellations in LEO, MEO, GEO and TLI.' Built upon Northrop Grummans Antares and Fireflys Alpha rocket, Eclipse offers a significant leap in power, performance, production cadence and payload capacity. The launch vehicle retains the flight-proven avionics from the Antares programme with additional upgrades, including a larger 5.4 meter payload fairing. Eclipse also utilises the same first stage Firefly is developing for Antares 330 and retains scaled-up versions of Alphas propulsion systems and carbon composite structures, allowing the team to rapidly build and test Eclipse with significant production efficiencies and economies of scale. Firefly utilised the same patented tap-off cycle architecture from Alphas Reaver and Lightning engines for Eclipses Miranda and Vira engines, and completed mission duty cycle with a 206 second Miranda hot fire, matching the longest time the engine will burn during a flight. Following several development test campaigns, flight hardware has been manufactured for the common dome propellant tanks, engine bay and interstage. Wendy Williams, Vice President and General Manager, Launch and Missile Defense Systems, Northrop Grumman, added: 'Eclipse gives customers the right balance between payload capacity and affordability. Our partnership with Firefly builds on our capacity to provide crucial spaced-based communication, observation, and exploration for civil and national security customers.' Filling a void in an underserved market, Eclipse is equipped to deliver 16,300 kg of cargo to low Earth orbit or 3,200 kg of cargo to geosynchronous transfer orbit. Eclipse will first launch from Wallops Island, Virginia, as early as 2026 and is able to support space station resupply, commercial spacecraft, critical national security missions and scientific payloads for the domestic and international markets.
